VK2735 shows strong early weight loss data, positioning Viking Therapeutics as a potential third major player in the booming GLP-1 obesity drug market. Learn more on VKTX stock here.

SHOPPING: Give your weight loss efforts a serious push with Hims, the weight loss program that is tailored to your unique ...

New rules are reshaping the telehealth market for GLP-1s like Ozempic and Wegovy, potentially impacting access to these drugs ...

Ozempic may have serious side effects, including thyroid cancer and problems with the pancreas, gallbladder, kidneys, and ...

People with poor mental health face many challenges. One that's perhaps lesser known is that they're more likely than the ...

Ozempic has gained a lot of popularity with many referring to it as the miracle weight loss drug However how much do you ...

UK health authorities are investigating pancreatitis cases linked to weight-loss drugs like Ozempic and Mounjaro. We spoke to doctors for clarity on risks, side effects, and the role of genetics.

While real-time data on how Indians are responding to these drugs is still emerging, experts say that sustained weight loss ...

Migraines are a common ailment worldwide, affecting nearly 15% of the global population. At times, they can be debilitating enough to interfere with daily activities. Despite a multitude of treatment ...

Both semaglutide and tirzepatide for type 2 diabetes and weight loss are GLP-1 agonists, meaning they mimic the hormone.

GLP-1 drugs currently being tested in China target complications associated with obesity such as heart disease, fatty liver ...

Hundreds of people have reported problems with their pancreas linked to taking weight loss and diabetes jabs, prompting ...